Patents Assigned to Roche Diagnostics GmbH
  • Patent number: 8119069
    Abstract: A test element analysis system for the analytical investigation of a liquid sample, comprising a test element including a carrier film having at least one flat side and a test field secured to the flat side and an evaluation instrument including a test element holder for positioning a test element in a measuring position, a measuring device for measuring the optically measurable change in the detection zone, and a housing within the measuring device is positioned. The test element is positioned in the measuring position in such a manner that a first partial section of the test element is located inside the housing and a second partial section is located outside of the housing to be easily accessible.
    Type: Grant
    Filed: October 7, 2010
    Date of Patent: February 21, 2012
    Assignee: Roche Diagnostics GmbH
    Inventors: Wolfgang Petrich, Wilfried Schmid, Gerrit Kocherscheidt, Jean-Michel Asfour
  • Publication number: 20110293708
    Abstract: The invention relates to a nucleic acid preparation with a content of below 1% protein, preferably below 0.1% protein, free of ethidium bromide, phenol, cesium chloride and detergents based on octyl phenol poly(ethylene glycol ether)n and with a content of below 1 EU/mg DNA of endotoxins. Said preparation is suitable as a drug particularly in gene therapy.
    Type: Application
    Filed: August 3, 2011
    Publication date: December 1, 2011
    Applicant: Roche Diagnostics GmbH
    Inventor: Wolfgang KUHNE
  • Publication number: 20110117561
    Abstract: Magnetic particles with an outer glass surface being essentially poreless or having pores of a diameter of less then 10 nm as well as ferromagnetic particles with a glass surface are preferentially useful for the isolation of biological material from samples. They provide a quick and reliable purification.
    Type: Application
    Filed: November 30, 2010
    Publication date: May 19, 2011
    Applicant: ROCHE DIAGNOSTICS GMBH
    Inventors: Jörg Kleiber, Thomas Walter, Herbert Harttig, Christoph Lesniak, Martin Mennig, Michael Riedling, Helmut Schmidt
  • Patent number: 7922694
    Abstract: A drive device for a piston in a container containing a liquid comprises a first segment positioned between a second segment and an outlet of the container. The first and second segments each have a first shape in which the respective segment is clamped between lateral walls of the container and a second shape in which the respective segment is released from the lateral walls. A first actuator is configured to vary the first segment between its first and second shapes, and the first segment is in its first shape when the first actuator is inactive. A second actuator is configured to vary the second segment between its first and second shapes, and the second segment is in its second shape when the second actuator is inactive. A connecting segment connects the first segment to the second segment and has an actively variable connecting length.
    Type: Grant
    Filed: September 14, 2006
    Date of Patent: April 12, 2011
    Assignee: Roche Diagnostics GmbH
    Inventor: Herbert Harttig
  • Publication number: 20110020898
    Abstract: A purified thermostable enzyme is derived form the thermophilic archaebacterium Thermococcus gorgonarius. The enzyme can be native or recombinant, retains approximately 90% of its activity after incubation for two hours at 95° C. in the presence of stabilizing agents and possesses 3?-5? proofreading exonuclease activity. Thermostable DNA polymerases are useful in many recombinant DNA techniques, especially nucleic acid amplification by the polymerase chain reaction (PCR).
    Type: Application
    Filed: June 3, 2010
    Publication date: January 27, 2011
    Applicant: Roche Diagnostics GmBH
    Inventors: Waltraud ANKENBAUER, Vitaly Svetlichny, Elizaveta Bonch-Osmolovskaya, Christine Ebenbichler, Bernhard Angerer, Gudrun Schmitz-Agheguian, Frank Laue
  • Patent number: 7863015
    Abstract: Device, method and kit for carrying out biochemical reactions, in particular for cell-free polypeptide biosynthesis composed of an external housing which encloses an inner housing with incorporated wells and a supply chamber, wherein the wells of the inner housing each contain a producing system during the biochemical reaction, the supply chamber contains a supply liquid during the biochemical reaction and the wells of the inner housing and the supply chamber are separated by a semipermeable membrane characterized in that the inner housing has at least two wells the lower ends of which are closed by a semipermeable membrane and the upper ends of which protrude from the supply liquid contained in the supply chamber, and is connected to means for moving and incubating the producing systems and to the supply liquid.
    Type: Grant
    Filed: September 12, 2005
    Date of Patent: January 4, 2011
    Assignee: Roche Diagnostics GmbH
    Inventors: Thomas Metzler, Hans Schels, Rolf Reichhuber, Jochen Kluge
  • Patent number: 7799578
    Abstract: The invention concerns a device and method for withdrawing samples of liquid samples for analytical elements. The device includes a carrier and a cover with a surface that cooperates with a surface of the carrier to form a channel. The channel has an opening defined by at least one edge. At least one notch in the form of a partial groove extends into the at least one edge of the opening so that one side of the edge of the opening is at least partially interrupted by the at least one notch. The notch forms a sample application opening by exposing the surface, whose extension forms an inner surface of the channel.
    Type: Grant
    Filed: May 29, 2007
    Date of Patent: September 21, 2010
    Assignee: Roche Diagnostics GmbH
    Inventor: Volker Zimmer
  • Patent number: 7759107
    Abstract: A purified thermostable enzyme is derived form the thermophilic archaebacterium Thermococcus gorgonarius. The enzyme can be native or recombinant, retains approximately 90% of its activity after incubation for two hours at 95° C. in the presence of stabilizing agents and possesses 3?-5? proofreading exonuclease activity. Thermostable DNA polymerases are useful in many recombinant DNA techniques, especially nucleic acid amplification by the polymerase chain reaction (PCR).
    Type: Grant
    Filed: June 9, 2008
    Date of Patent: July 20, 2010
    Assignee: Roche Diagnostics GmbH
    Inventors: Waltraud Ankenbauer, Vitaly Svetlichny, Elizaveta Bonch-Osmolovskaya, Christine Ebenbichler, Bernhard Angerer, Gudrun Schmitz-Agheguian, Frank Laue
  • Publication number: 20100136519
    Abstract: The invention concerns a process for the immunological determination of a specific antibody in a fluid sample. The process involves incubating the fluid sample in the presence of a solid phase with two antigens directed against the antibody whose presence is to be determined; the first antigen carries at least one marker group, while the second is either (a) bonded to the solid phase or (b) present in a form in which it can bond with the solid phase, and betrays the presence of the antibody being sought by showing the presence of the marker group in the solid phase and/or in the fluid phase. The proposed process is characterised by the fact that at least one of the two antigens has several epitopic regions which react with the antibody to be determined.
    Type: Application
    Filed: October 27, 2009
    Publication date: June 3, 2010
    Applicant: Roche Diagnostics GmbH
    Inventors: Ursula-Henrike Wienhues, Cornelia Kruse-Müller, Eva Höss, Elke Faatz, Beatus Ofenloch-Hähnle, Christoph Seidel, Michael Wiedmann
  • Publication number: 20100074946
    Abstract: The invention relates to a nucleic acid preparation with a content of below 1% protein, preferably below 0.1% protein, free of ethidium bromide, phenol, cesium chloride and detergents based on octyl phenol poly(ethylene glycol ether)n and with a content of below 1EU/mg DNA of endotoxins. Said preparation is suitable as a drug particularly in gene therapy.
    Type: Application
    Filed: November 30, 2009
    Publication date: March 25, 2010
    Applicant: Roche Diagnostics GmbH
    Inventor: Wolfgang KUHNE
  • Patent number: 7659373
    Abstract: The invention concerns new EPO compositions with high specific activity which are characterized by a high proportion of N-acetyl-lactosamine units or/and tetraantennary branches in the carbohydrate structure. In addition the invention concerns a process for producing such EPO products.
    Type: Grant
    Filed: August 9, 2005
    Date of Patent: February 9, 2010
    Assignee: Roche Diagnostics GmbH
    Inventors: Josef Burg, Karl-Heinz Sellinger, Anton Haselbeck, Hans Koll
  • Patent number: 7629295
    Abstract: The invention concerns a method for the immunological determination of a specific antibody in a sample liquid in which the sample liquid is incubated in the presence of a solid phase with two antigens directed against the antibody to be determined of which the first antigen carries at least one marker group and the second antigen is (a) bound to the solid phase or (b) is present in a form capable of binding to the solid phase and the antibody to be determined is detected by determining the marker group in the solid phase or/and in the liquid phase characterized in that at least one of the two antigens contains several epitope regions which react with the antibody to be determined.
    Type: Grant
    Filed: July 7, 2003
    Date of Patent: December 8, 2009
    Assignee: Roche Diagnostics GmbH
    Inventors: Ursula-Henrike Wienhues, Cornelia Kruse-Müller, Eva Höss, Elke Faatz, Beatus Ofenloch-Hähnle, Christoph Seidel, Michael Wiedmann
  • Patent number: 7612187
    Abstract: Within oligonucleotides 2-azapurine and especially 2-azaadenine bases form specifically base pairs with guanine. This base pair is of analogous stability as an adenine-thymine but less stable than a guanine-cytosine base pair. Therefore, the incorporation of 2-azaadenine residues into oligonucleotides instead of cytosine leads specifically to hybridization complexes with nucleic acids with homogenous stability. This is useful for the adaptation of the stabilities of different oligonucleotide sequences in all kinds of hybridization techniques, for example in oligomer chip technology.
    Type: Grant
    Filed: May 25, 2006
    Date of Patent: November 3, 2009
    Assignee: Roche Diagnostics, GmbH
    Inventors: Frank Seela, Helmut Rosemeyer, Enno Schweinberger, Dieter Heindl, Frank Bergmann
  • Patent number: 7569187
    Abstract: A method and a device for removing an analytic consumable product, in particular a test element, from a storage container having chambers which are sealed by foils from which the consumable product is pushed out by means of a plunger (7) can be optimized in that the magnitude of the thrusting force exercised by the plunger (7) during its forward motion can be controlled in dependence on the plunger (7) position.
    Type: Grant
    Filed: October 1, 2002
    Date of Patent: August 4, 2009
    Assignee: Roche Diagnostics GmbH
    Inventors: Michael Schabbach, Karl Miltner, Thomas Klemm, Rolf Baumann, Meinrad Dilger
  • Publication number: 20090191558
    Abstract: The present invention relates to new nucleic acid sequences derived from the ITS (Internal Transcribed Spacer) region, between the 16S and 23S rRNA genes, to be used for the specific detection and/or identification of Serratia species, in particular of Serratia marcescens, Serratia ficaria and/or Serratia fonticola, in a biological sample. The present invention relates also to a method for the specific detection and/or identification of Serratia species, in particular Serratia marcescens, Serratia ficaria and/or Serratia fonticola, using said new nucleic acid sequences derived from the ITS region. It relates also to nucleic acid primers to be used for the amplification of said spacer region of Serratia species in a sample.
    Type: Application
    Filed: December 9, 2008
    Publication date: July 30, 2009
    Applicants: Innogenetics, N.V., Roche Diagnostics GmbH
    Inventors: Geert JANNES, Wouter Mijs, Thomas Emrich, Gerd Haberhausen
  • Patent number: 7547417
    Abstract: A storage container for holding analytical devices, the storage container being made of a rigid material and containing separate chambers in each of which at most one analytical device can be accommodated, wherein the chambers are in a regular geometric arrangement in relation to one another and each of the chambers has at least two opposite openings each sealed by a foil, wherein at least one of the chambers comprises a means for fixing the position of an analytical device in the chamber. In addition the invention concerns a system for storing analytical devices containing a storage container according to the invention and two or more analytical devices.
    Type: Grant
    Filed: October 2, 2002
    Date of Patent: June 16, 2009
    Assignee: Roche Diagnostics GmbH
    Inventor: Klaus-Dieter Sacherer
  • Publication number: 20090098558
    Abstract: The present invention relates to new nucleic acid sequences derived from the ITS region, between the 16S and 23S ribosomal ribionucleic acid (rRNA) or rRNA genes, to be used for the specific detection and/or identification of Proteus species, in particular of Proteus mirabilis, Proteus vulgaris and/or Proteus penneri in a biological sample. The present invention relates also to a method for the specific detection and/or identification of Proteus species, in particular Proteus mirabilis, Proteus vulgaris and/or Proteus penneri, using said new nucleic acid sequences derived from the ITS (Internal Transcribed Spacer) region. It relates also to nucleic acid primers to be used for the amplification of said spacer region of Proteus species in a sample.
    Type: Application
    Filed: October 16, 2008
    Publication date: April 16, 2009
    Applicants: INNOGENETICS N.V., ROCHE DIAGNOSTICS GmbH
    Inventors: Geert Jannes, Wouter Mijs, Gerd Haberhausen, Thomas Emrich
  • Publication number: 20090093043
    Abstract: A purified thermostable enzyme is derived form the thermophilic archaebacterium Thermococcus gorgonarius. The enzyme can be native or recombinant, retains approximately 90% of its activity after incubation for two hours at 95° C. in the presence of stabilizing agents and possesses 3?-5? proofreading exonuclease activity. Thermostable DNA polymerases are useful in many recombinant DNA techniques, especially nucleic acid amplification by the polymerase chain reaction (PCR).
    Type: Application
    Filed: June 9, 2008
    Publication date: April 9, 2009
    Applicant: Roche Diagnostics GmBH
    Inventors: Waltraud Ankenbauer, Vitaly Svetlichny, Elizaveta Bonch-Osmolovskaya, Christine Ebenbichler, Bernhard Angerer, Gudrun Schmitz-Agheguian, Frank Laue
  • Patent number: 7479253
    Abstract: A flat-shaped functional overlay for at least one region of a flat-shaped flexible object which does not form a fold when the sandwich composed of the flexible object and overlay is bent towards the side on which the overlay is located is described. The overlay is composed of one or several flat-shaped overlays which are attached to the flexible object in such a way that a part of their surface can move freely relative to the surface of the object covered by this part in the direction of curvature produced when the object is bent. In addition diagnostic test strips are described which have such an overlay.
    Type: Grant
    Filed: February 7, 2003
    Date of Patent: January 20, 2009
    Assignee: Roche Diagnostics GmbH
    Inventors: Wolfgang-Reinhold Knappe, Helmut Leininger, Ralf Steinbrueck, Franz Wittmann
  • Publication number: 20090017456
    Abstract: The present invention relates to a method for the specific detection and/or identification of Enterococcus species, in particular Enterococcus faecalis and/or Enterococcus faecium, using new nucleic acid sequences derived from the ITS (Internal Transcribed Spacer) region. The present invention relates also to said new nucleic acid sequences derived from the ITS region, between the 16S and 23S ribosomal ribonucleic acid (rRNA) or rRNA genes, to be used for the specific detection and/or identification of Enterococcus species, in particular of Enterococcus faecalis and/or Enterococcus faecium, in a biological sample. It relates also to nucleic acid primers to be used for the amplification of said spacer region of Enterococcus species in a sample.
    Type: Application
    Filed: March 10, 2008
    Publication date: January 15, 2009
    Applicants: INNOGENETICS N.V., ROCHE DIAGNOSTICS GMBH,
    Inventors: Hilde DE HENAU, Joachim Van Crombruggen, Geert Jannes, Gerd Haberhausen, Thomas Emrich